<?xml version="1.0" encoding="UTF-8"?>
<ref id="B53-ijerph-17-01686">
 <label>53.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Pebody</surname>
    <given-names>R.G.</given-names>
   </name>
   <name>
    <surname>Gay</surname>
    <given-names>N.J.</given-names>
   </name>
   <name>
    <surname>Hesketh</surname>
    <given-names>L.M.</given-names>
   </name>
   <name>
    <surname>Vyse</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Morgan-Capner</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Brown</surname>
    <given-names>D.W.</given-names>
   </name>
   <name>
    <surname>Litton</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Miller</surname>
    <given-names>E.</given-names>
   </name>
  </person-group>
  <article-title>Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance</article-title>
  <source>Vaccine</source>
  <year>2002</year>
  <volume>20</volume>
  <fpage>1134</fpage>
  <lpage>1140</lpage>
  <pub-id pub-id-type="doi">10.1016/S0264-410X(01)00435-2</pub-id>
  <pub-id pub-id-type="pmid">11803074</pub-id>
 </element-citation>
</ref>
